Plasma hyaluronidase activity as an indicator of atherosclerosis in patients with coronary artery disease

Bratislava Medical Journal

Volumn 110, Issue 1, 2009, Pages 21-26

  Kucur, Mine ^a   Karadag, Bilgehan ^a   Isman, Ferruh K ^b   Ataev, Yusup ^a   Duman, Dursun ^c   Karadag, Nalan ^a   Ongen, Zeki ^a   Vural, Vural A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Atherosclerosis; Coronary artery disease; Hyaluronan; Hyaluronidase

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYALURONOGLUCOSAMINIDASE;

ARTICLE; ATHEROSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; ENZYMOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED;

EID: 70349499222     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 2002; 277 (7): 4593-4596.
2. Papakonstantinou E, Roth M, Block LH, Mirtsou-Fidani V, Argiriadis P, Karakiulakis G. The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis 1998; 138 (1): 79-89.
3. Levegue H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyalu ronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis 1994; 105 (1): 51-62.
4. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ, Stroes ES. Loss of endothelial glycocalyx during acu te hyperglycemia coincides with endothelial dysfunction and coagula tion activation in vivo. Diabetes 2006; 55 (2): 480-486.
5. Henry CB, Duling BR. Permeation of the luminal capillary glycoca lyx is determined by hyaluronan. Amer J Physiol 1999; 277 (2 Pt 2): H508-14.
6. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circulat Res 2003; 92 (6): 592-594.
7. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 2005; 16 (5): 507-511.
8. Koernerup K, Nordestgaard BG, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Jensen JS. Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 2003; 170 (1): 163-168.
9. Nieuwdorp M, Holleman F, de Groot J, Kontush A, Chapman MJ, Hutten BA, Brouwer CB, Hoesktra JB, Kastelein JJ, Stroes ES. Pertubation of hyaluronan metabolism predisposes patients with type 1 dia betes mellitus to atherosclerosis. Diabetologia 2007; 50 (6): 1288-1293.
10. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006; 55 (4): 1127-1132.
11. Montesano R, Kumar S, Orci L, Pepper MS. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 1996; 75 (2): 249-262.
12. Riessen R, Wight TN, Pastore C, Hensley C, Isner JM. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996; 93 (6): 1141-1147.
13. Fern GA, Konneh M, Rutherford C, Woolaghan E, Anggard EE. Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit. Atherosclerosis 1995; 114 (2): 157-164.
14. Lindqvist U. Is serum hyaluronan a helpful tool in the management of patients with liver diseases? J Intern Med 1997; 242 (1): 67-71.
15. Reissig JL, Strominger JL, Leloir LF. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem 1955; 217: 956-966.
16. Natowicz MR, Wang Yu. Human serum hyaluronidase: characterization of a clinical assay. Clin Chim Acta 1996; 245: 1-6.
17. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vase Biol 1999; 19 (4): 1004-1013.
18. Frost GI, Csoka AB, Wong T, Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997; 236 (1): 10-15. Erratum in: Biochem Biophys Res Commun2004; 319 (2): 705.
19. McGuire PG, Castellot JJ Jr, Orkin RW. Size-dependent hyaluronate degradation by cultured cells. J Cell Physiol 1987; 133 (2): 267-276.
20. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002; 277 (7): 4581-4584.
21. Ross R. Atherosclerosis: an inflammatory disease. New Engl J Med 1999; 340: 115-126.
22. Savani RC, Turley EA. The role of hyaluronan and its receptors in restenosis after balloon angioplasty: development of a potential therapy. Int J Tissue React 1995; 17 (4): 141-151.
23. Srinivasan SR, Yost K, Radhakrishnamurthy B, Dalferes ER Jr, Berenson GS. Lipoprotein-hyaluronate associations in human aorta fib rous plaque lesions. Atherosclerosis 1980; 36 (1): 25-37.
24. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Amer J Pathol 1998; 152 (2): 533-546.
25. Danesh J, Muir J, Wong, YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999; 20: 954-959.
26. Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y. Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J 2006; 53 (6): 761-766.
27. Chajara A, Raoudi M, Delpech B, Meroy M, Basuyau JP, Levesque H. Increased hyaluronan and hyaluronidase production and hya luronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vase Biol 2000; 20 (6): 1480-1487.
28. van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, Grabitz K, Levkau B, Schror K, Fischer JW. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circulat Res; 98 (1): 36-44.